Development of an AI Solution to Evaluate Clinical Activity of TAO Using Periocular Images Taken by Smartphones in Patients With Thyroid Dysfunction
Development of an Artificial Intelligence Solution to Evaluate Clinical Activity of Thyroid Associated Orbitopathy Using Periocular Selfie Images Taken by Smartphones in Patients With Thyroid Dysfunction
1 other identifier
observational
100
1 country
1
Brief Summary
This study was conducted to develop an AI solution to evaluate clinical activity score (CAS) of thyroid associated orbitopathy (TAO) using periocular selfie images taken by smartphones in patients with thyroid dysfunction. An AI solution to evaluate CAS in TAO was developed in previous retrospective study using periorbital digital images taken by DSLR camera in the studio. This AI solution will be adjusted to show its best performance with periocular selfie images taken by smartphones.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 22, 2021
CompletedFirst Submitted
Initial submission to the registry
April 17, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 18, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 25, 2022
CompletedFirst Posted
Study publicly available on registry
February 16, 2023
CompletedFebruary 16, 2023
February 1, 2023
7 months
April 17, 2022
February 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Accuracy for clinical activity score (CAS) of thyroid eye disease (TED)
Accuracy of AI solution using smartphone selfie images for CAS of TED.
baseline (this study has no intervention)
Diagnostic accuracy for active thyroid eye disease
Accuracy of AI solution using smartphone selfie images for active thyroid eye disease (TED) which is defined as 3 or more of clinical activity score
baseline (this study has no intervention)
Secondary Outcomes (5)
Accuracy for redness of eyelids
baseline (this study has no intervention)
Accuracy for redness of conjunctiva
baseline (this study has no intervention)
Accuracy for swelling of eyelids
baseline (this study has no intervention)
Accuracy for swelling of conjunctiva
baseline (this study has no intervention)
Accuracy for swelling of caruncle
baseline (this study has no intervention)
Study Arms (1)
thyroid eye disease group
Patients who were diagnosed as thyroid eye disease. Periorbital images are taken by DSLR camera in the studio. Periorbital selfie images are taken by the patients with 6 smartphones including various camera modules. CAS of TAO is evaluated by 3 ophthalmologists based on the periorbital digital images taken by DSLR camera and symptoms.
Interventions
taking periorbital selfie images using smartphones
Eligibility Criteria
This study is conducted to develop AI solution using smartphone selfie images. Therefore, the number of subjects for this study was calculated as 200, the maximum number of patients with thyroid eye disease that can be prospectively recruited during the study period.
You may qualify if:
- Patients with thyroid eye disease
You may not qualify if:
- Patients who have prior facial anomaly or surgery
- Patients who cannot use smartphone camera app
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Seoul National University Bundang Hospitallead
- THYROSCOPE INC.collaborator
Study Sites (1)
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 13620, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Namju Kim, MD, PhD.
Seoul National University Bundang Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 17, 2022
First Posted
February 16, 2023
Study Start
December 22, 2021
Primary Completion
July 18, 2022
Study Completion
July 25, 2022
Last Updated
February 16, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared.